← FDA Drug Approvals (Drugs@FDA)
DAPSONE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: PADAGIS ISRAEL · Approved 2023-11-01
Drug application
- FDA Application #
ANDA212657- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- DAPSONE
- Generic name
- Dapsone
- Active ingredients
- DAPSONE
- Dosage form
- GEL
- Route
- TOPICAL
- Marketing status
- Discontinued
- Sponsor
- PADAGIS ISRAEL
- First approval
- 2023-11-01
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown